EBITDA up 59% to $2.1m H1 FY18.Strong growth yet again. Great appointment to head of sales also. Strength to strength.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025